EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SELENOF and its translational inhibitor EIF4A3 are differentially expressed in colon cancer

Avneet Shaheed, Shriya Mehta, Maria Sverdlov, Ryan Deaton, Irida Kastrati, John T Phoenix, Steven Kregel, Alan M Diamond, Soumen Bera

Archives of Biochemistry and Biophysics · 2026-06 · 780 · 110796

DOI: 10.1016/j.abb.2026.110796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-06. Verfasst von Avneet Shaheed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, Chicago, IL, 60612, USA. Hauptthemen laut MEDLINE: Eukaryotic Initiation Factor-4A, Selenoproteins, Colonic Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, US Department of Defense Prostate Cancer Research Program, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eukaryotic Initiation Factor-4ASelenoproteinsColonic NeoplasmsGene Expression Regulation, NeoplasticHumansCell Line, Tumor3' Untranslated RegionsAdenocarcinomaDEAD-box RNA Helicases

Stichwörter der Autor:innen

3′-UTRColon adenocarcinomaEIF4A3Motif analysisSELENOFSurvival analysis

Substanzen

Eukaryotic Initiation Factor-4ASelenoproteinsEIF4A3 protein, human3' Untranslated RegionsDEAD-box RNA Helicases

Autor:innen und Institutionen

  • Department of Pathology, College of Medicine, Chicago, IL, 60612, USA.
  • Department of Pathology, College of Medicine, Chicago, IL, 60612, USA; Research Resources Center, University of Illinois at Chicago, Chicago, IL, 60612, USA.
  • Department of Cancer Biology, Loyola University Chicago, Maywood, IL, 601534, USA.
  • Department of Pathology, College of Medicine, Chicago, IL, 60612, USA; School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, Tamil Nadu, India. Electronic address: sbera@uic.e…

Förderung

  • NCI NIH HHS
  • US Department of Defense Prostate Cancer Research Program
  • National Institutes of Health National Cancer Institute
  • National Institutes of Health
  • U.S. Department of Defense

Zitieren

APA

Shaheed, A., Mehta, S., Sverdlov, M., Deaton, R., Kastrati, I., Phoenix, J. T., Kregel, S., Diamond, A. M., & Bera, S. (2026). SELENOF and its translational inhibitor EIF4A3 are differentially expressed in colon cancer. Archives of Biochemistry and Biophysics, 780, 110796. https://doi.org/10.1016/j.abb.2026.110796

Vancouver

Shaheed A, Mehta S, Sverdlov M, Deaton R, Kastrati I, Phoenix JT, et al. SELENOF and its translational inhibitor EIF4A3 are differentially expressed in colon cancer. Archives of Biochemistry and Biophysics. 2026;780:110796. doi:10.1016/j.abb.2026.110796

BibTeX
@article{Shaheed2026,
  author = {Shaheed, Avneet and Mehta, Shriya and Sverdlov, Maria and Deaton, Ryan and Kastrati, Irida and Phoenix, John T and Kregel, Steven and Diamond, Alan M and Bera, Soumen},
  title = {SELENOF and its translational inhibitor EIF4A3 are differentially expressed in colon cancer},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2026},
  volume = {780},
  pages = {110796},
  doi = {10.1016/j.abb.2026.110796}
}
Kostenlos starten →